Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Clin Endocrinol (Oxf). 2016 Jan 25;84(5):693–699. doi: 10.1111/cen.12990

Table 1.

Characteristics of male participants at EDIC year 10 (n=508), means (SD) or n (%).

Total testosterone (nmol/l) 20.9 (7.1)
Bioavailable testosterone (nmol/l) 0.34 (0.08)
Sex hormone binding globulin (nmol/l) 55.3 (23.6)
Age (years) 45 (6)
Randomization arm (n,%)
 Conventional 259 (51%)
 Intensive 249 (49%)
Primary cohort (n,%) 257 (51%)
Current smoking (n,%) 59 (12%)
Current alcohol use (n,%) 260 (51%)
Body mass index (n,%)
 < 25 kg/m2 173 (34%)
 25-29.9 kg/m2 288 (57%)
 ≥30 kg/m2 47 (9%)
Time-weighted body mass index (kg/m2) 26.1 (2.8)
Time-weighted insulin dose (units/kg/day) 0.7 (0.2)
Time-weighted DCCT/EDIC HbA1c (mmol/mol) 64 (11)
Anti-hypertensive medication use (%) 279 (55%)
Time-weighted systolic blood pressure (mm Hg) 120 (8)
Time-weighted low-density lipoprotein cholesterol (mg/dl) 114 (23)
Time-weighted high-density lipoprotein cholesterol (mg/dl) 49 (11)
History of albumin excretion ratio ≥ 300 mg/24 hours (n, %) 49 (10%)
Left ventricular mass index (g/m2) 76.5 (12.3)
End-diastolic volume (ml/m2) 73.3 (12.6)
End-systolic volume (ml/m2) 29.2 (7.8)
Stroke volume index (ml/m2) 44.1 (8.0)
Ejection fraction (%) 60.3 (6.3)
Cardiac output (L• min-1•m-2) 3.1 (0.6)
Left ventricular mass/end-diastolic volume (mg/ml) 1.1 (0.2)